Hold the token.
Earn live peptide stocks.
$PEPSHARE is a Solana memecoin. Every trade fee sweeps into a basket of publicly-listed peptide & GLP-1 equities, then mirrors that exposure back to every holder — pro-rata, every 30 minutes. No claim. No signature.
Fees in. Peptides out.
A Solana program collects trade fees, rebalances into tokenized peptide-pharma equities, then streams the exposure back to every holder. Fully on-chain. No claim.
Acquire $PEPSHARE in any Solana wallet. Holding is the only requirement.
Every buy and sell routes 100% of the fee to the on-chain treasury.
Treasury rebalances into a basket of tokenized peptide equities.
Exposure is streamed pro-rata to every wallet — no signature required.
What the treasury buys.
Every cycle, fees rotate into a curated basket of publicly-listed peptide & GLP-1 names. Large-cap leaders, small-cap challengers — held as tokenized equity, on-chain.
Eli Lilly and Company
The market leader in dual-agonist GLP-1 / GIP therapy. Anchor position in the basket.
Novo Nordisk
The original GLP-1 incumbent. Decades of peptide manufacturing depth behind it.